Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, September 17, 2019
Parexel has formed alliances with three healthcare institutions - PKUCare Luzhong Hospital, West China Medical Center, and Shanghai Xuhui Central Hospital.
read more
Tuesday, November 10, 2015
PAREXEL International Corporation, a global biopharmaceutical services provider, has announced expanded evidence-based services for biopharmaceutical products.
read more
Thursday, January 26, 2017
PAREXEL International Corporation (NASDAQ: PRXL), a global biopharmaceutical services provider, has launched an expanded Managed Access Programs service. PAREXEL now offers end-to-end expertise for the design, development, and delivery of managed ...
read more
Thursday, October 31, 2019
Parexel announced the expansion of its collaboration with the Society for Clinical Research Sites (SCRS).
read more
Wednesday, November 18, 2015
PAREXEL International Corporation has announced the enhancement of its end-to-end clinical development services through its new process, called Clinical Development Optimization.
read more
Parexel has completed the separation of its Parexel Informatics and Medical Imaging business.
read more
Wednesday, December 05, 2018
PAREXEL has announced a new collaboration with Eli Lilly and Company to launch a clinical research learning and development program in China
read more
PAREXEL International (NASDAQ: PRXL), a leading global biopharmaceutical services organization, today announced the appointment of Peter Steiger, Ph.D., to the newly created position of Vice President and Chief Scientific Officer for Medical Imaging....
read more
PAREXEL International Corporation, a global biopharmaceutical services provider, has announced the appointment of four company executives to its senior-most leadership team, the Business Review Committee.
read more
Thursday, December 12, 2019
Parexel announced the appointment of four experts to its Regulatory Consulting group.
read more
Wednesday, February 13, 2019
PAREXEL announced the appointment of four former senior executives from the FDA to its Regulatory Consulting group.
read more
PAREXEL announced the appointment of Jamie Macdonald as Chief Executive Officer (CEO) effective March 15, 2018.
read more
Parexel unveiled its COVID-19 Risk Mitigation offering, which leverages the company’s experience with global viral outbreaks as well as cGMP inspection and CMC review processes to ensure that manufacturers can safely and confidently continue ...
read more
Wednesday, February 27, 2019
PAREXEL announced several new appointments that will enhance the company’s oncology expertise as oncology trials grow in number and complexity.
read more
PAREXEL International Corporation, a global biopharmaceutical services provider, has signed a services agreement with Pfizer Inc. Under the terms of this agreement, PAREXEL will continue to provide global clinical research and development services to...
read more